AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06498401 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: gut microbiota-targeted dietary intervention
Description: The dietary intervention targeted at gut microbiota. Each participant's dietary habits,food preferences and economic level were taken into account. The dietary intervention was delivered by sending meals. To ensure the freshness and quality of the ingredients, 2 dedicated researchers were jointly responsible for the procurement of fresh ingredients, which were purchased through regular channels on Monday, Wednesday and Friday mornings. Meals will be delivered three times a week for a 12-week intervention period. Guided dietary follow-up was conducted through WeChat or telephone follow-up. The researcher will provide cooking instruction or dietary pattern guidance every two weeks.
Study NCT06416150 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage 2 HERS
Description: Participants will receive another barriers assessment and another round of text message appointment reminders and barriers messages.
Study NCT06416150 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage 2 HERS+HC
Description: Participants will receive another barriers assessment and another round of text message barriers counseling as well as health coaching (HC) after their missed appointment. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.
Study NCT06416150 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage 3 SOC
Description: Participants will receive a telephone call before their 12-month follow-up appointments to remind participants about their upcoming appointment and schedule/reschedule if needed.
Study NCT06416150 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage 3 HERS
Description: Participants will receive text message appointment reminders and barriers messages. Text messages will be sent on a prescheduled basis over the course of 2 weeks preceding the scheduled target appointment.
Study NCT06416150 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage 3 HERS+HC
Description: Participants will receive text message barriers counseling as well as HC after their missed appointment. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.
Study NCT06416150 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage 4 HERS
Description: Participants will receive another barriers assessment and another round of text message appointment reminders and barriers messages.
Study NCT06416150 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage 4 HERS+HC
Description: Participants will receive another barriers assessment and another round of text message barriers counseling as well as HC. Participants that miss their scheduled appointment will receive a HC call within 2 business days. HC calls will be flexibly scheduled based on the preference of the patients and limited to 15 minutes or less.
Study NCT06474520 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Calculus bovis sativus (CBS)
Description: Subjects will orally receive 100mg CBS per day from day 1 to day 84.
Study NCT05977816 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy
Description: Application of a negative wound pressure therapy dressing to the wound post laparotomy
Study NCT05977816 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard wound dressing
Description: Application of a standard wound dressing to the wound post laparotomy
Study NCT04930861 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Covidir injections
Description: administration of the investigational product CODIVIR at a dose of 20 mg twice a day subcutaneously.
Study NCT04930861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: One Step Test
Description: rapid test for the diagnosis of COVID-19 based on the detection of anti-SARS-CoV-2 in the blood.
Study NCT04930861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: IgM and IgG dosage
Description: blood collection for dosage of Anti SARS-CoV-2 antibodies.
Study NCT04930861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: RT-PCR SARS-CoV-2
Description: detection of viral RNA in nasopharyngeal and oropharyngeal samples by the Real Time Protein Chain Reaction technique.
Study NCT04930861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Screening blood test
Description: complete blood count, urea, creatinine, uric acid, sodium, potassium, chloride, calcium, glucose, glycated hemoglobin, alkaline phosphatase (FA), alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubins and fractions ( BTF), total proteins and fractions (PTF), lipid profile (total cholesterol, fractions and triglycerides); coagulogram (TP, aPTT); D-dimer; C-reactive protein; HIV, HBV, HCV serology; Ferritin; fibrinogen, Pregnancy test for non-sterile women.
Study NCT04930861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: ECG
Description: 12-lead electrocardiogram with report.
Study NCT04930861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Medical evaluation
Description: evaluation by the principal investigator or assistant physician with a complete physical examination.
Study NCT04930861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: NEWS-2 score
Description: assessment of the participant by the NEWS-2 score.
Study NCT04930861 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: WHO score
Description: assessment of the participant by the score of the World Health Organization.
Study NCT05129657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product A
Description: Usual Brand (UB) filtered, non-menthol or menthol cigarette
Study NCT04839809 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Oral
Study NCT06432790 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CHAMPION
Description: The CHAMPION program is an intensive health behavior and lifestyle treatment (IHBLT), formed through the integration of the Healthy Weight Clinic IHBLT and with MGB's pediatric Asthma Population Health Management Program. It consists of 30 hours of contact time with the CHAMPION team (physician, dietician, community health worker), consistent with the USPSTF and AAP recommendations, monthly individual clinic visits with the team (in person or virtual, per randomization), health coaching calls with a community health worker and/or registered dietician, monthly group sessions (in the first six months), and educational materials for families that reinforce healthy lifestyle behaviors and provide self-management education. In this study, all participants will participate in CHAMPION, but one arm will receive the experimental form (delivery via telehealth) and the other arm will receive the active comparator (delivery via telehealth).
Study NCT06432790 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: CHAMPION
Description: The CHAMPION program is an intensive health behavior and lifestyle treatment (IHBLT), formed through the integration of the Healthy Weight Clinic IHBLT and with MGB's pediatric Asthma Population Health Management Program. It consists of 30 hours of contact time with the CHAMPION team (physician, dietician, community health worker), consistent with the USPSTF and AAP recommendations, monthly individual clinic visits with the team (in person or virtual, per randomization), health coaching calls with a community health worker and/or registered dietician, monthly group sessions (in the first six months), and educational materials for families that reinforce healthy lifestyle behaviors and provide self-management education. In this study, all participants will participate in CHAMPION, but one arm will receive the experimental form (delivery via telehealth) and the other arm will receive the active comparator (delivery via telehealth).
Study NCT05711693 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser doppler vibrometry (LDV), heart(cordium) carotid pulse wave velocity (ccPWV)
Description: Patients scheduled for thoracic aorta MRI will have LDV measurement of ccPWV. Both techniques will be compared
Study NCT05711693 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood pressure and heart rate measurement
Description: To all patients:~- blood pressure and heart rate will be measured
Study NCT05711693 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: carotid to femoral PWW measurement
Description: To all patients:~- carotid to femoral PWW will be measured by LDV and tonometry for comparison
Study NCT05711693 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Questionnaire completion
Description: All patients will complete a questionnaire of acceptability
Study NCT02749552 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy
Description: weight-related interventions using values, acceptance, and mindfulness based on Acceptance and Commitment Therapy
Study NCT05129657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product B
Description: P1012914, A nicotine pouch product with 4 mg of nicotine
Study NCT05608694 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Prostate MRI
Description: Group placement is determined by GRS score, Family history, and germline testing
Study NCT06045936 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine
Description: 2 teaspoons of 2% lidocaine injection
Study NCT06045936 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Saline injection
Study NCT05181215 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Monomethyl Fumarate 190 Mg
Description: 2 x oral 95 mg capsules, delayed-release
Study NCT05181215 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diroximel Fumarate 462 mg
Description: 2 x 231 mg capsules, delayed-release
Study NCT05955729 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: On-duty Nap
Description: For 12 weeks, an opportunity for a 30-minute nap during the night shift, between 1 a.m. and 4 a.m., in a quiet room with facilities for lying down.
Study NCT05955729 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control condition (30-min rest)
Description: For 12 weeks, an opportunity for a 30-minute rest during the night shift, between 1 a.m. and 4 a.m., in a quiet room without facilities for lying down or napping.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: EndoPAT
Description: The EndoPAT device® measures vascular reactivity after a 5-minute occlusion on one arm.~This device measures changes in vascular tone induced by the endothelium at fingertip level using a pair of plethysmographic sensors. The measurement consists of performing a reference recording for 5 minutes on the 2 arms, then a test arm is chosen to perform an occlusion for 5 minutes while continuing the recording.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: EndoPAT
Description: The EndoPAT device® measures vascular reactivity after a 5-minute occlusion on one arm.~This device measures changes in vascular tone induced by the endothelium at fingertip level using a pair of plethysmographic sensors. The measurement consists of performing a reference recording for 5 minutes on the 2 arms, then a test arm is chosen to perform an occlusion for 5 minutes while continuing the recording.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Popmeter®
Description: The tool is connected to the caregiver's finger and toe via photodiode sensors. Its simple operation enables reproducible measurement of the propagation speed of the pulse wave in 14 seconds.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Popmeter®
Description: The tool is connected to the caregiver's finger and toe via photodiode sensors. Its simple operation enables reproducible measurement of the propagation speed of the pulse wave in 14 seconds.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Panasonic EW3109
Description: Diastolic and systolic blood pressure measured 3 times in succession using an automatic blood pressure monitor (Panasonic EW3109) in the sitting position on the left arm.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Panasonic EW3109
Description: Diastolic and systolic blood pressure measured 3 times in succession using an automatic blood pressure monitor (Panasonic EW3109) in the sitting position on the left arm.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ECG Holter
Description: The Holter takes an ECG during the subject's daily activities at home.
Study NCT05955729 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ECG Holter
Description: The Holter takes an ECG during the subject's daily activities at home.
Study NCT05955729 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Fasting blood sample
Description: 15 ml blood sample (venous sampling) will be taken to measure inflammatory biomarkers (hsCRP, IL-6 TNF-α, IL-1β) and blood markers of endothelial function (NO, CRP, SOD, IL-18).
Study NCT05955729 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Fasting blood sample
Description: 15 ml blood sample (venous sampling) will be taken to measure inflammatory biomarkers (hsCRP, IL-6 TNF-α, IL-1β) and blood markers of endothelial function (NO, CRP, SOD, IL-18).
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pichot fatigue scale
Description: The Pichot fatigue scale is an 8-item questionnaire, with a score above 22 indicating excessive fatigue.
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pichot fatigue scale
Description: The Pichot fatigue scale is an 8-item questionnaire, with a score above 22 indicating excessive fatigue.
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: French version of the Recovery Needs Scale (BRD)
Description: BRD questionnaire consists of 11 items coded 0 or 1. A score is calculated for each participant, multiplied by 10 to give a score ranging from 0 to 100. The greater the need for recovery, the higher the score.
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: French version of the Recovery Needs Scale (BRD)
Description: BRD questionnaire consists of 11 items coded 0 or 1. A score is calculated for each participant, multiplied by 10 to give a score ranging from 0 to 100. The greater the need for recovery, the higher the score.
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The Short-Form 36 (SF-36)
Description: The SF-36 questionnaire is used to assess quality of life. It comprises 8 sub-scores ranging from 0 (minimum quality of life) to 100 (maximum well-being).
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Short-Form 36 (SF-36)
Description: The SF-36 questionnaire is used to assess quality of life. It comprises 8 sub-scores ranging from 0 (minimum quality of life) to 100 (maximum well-being).
Study NCT06446050 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: MSC-L
Description: Human umbilical cord-derived mesenchymal stem cells (MSCs) genetically modified to express antitumor chemokine and co-stimulatory molecule will be administered intravenously at a dose of 1/2/3 x 10\^6 cells/kg, every 21 days for at least 6 cycles of treatment.
Study NCT04785144 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273
Description: Lipid nanoparticle (LNP) dispersion containing an mRNA that encodes for the pre fusion stabilized spike protein of the Wuhan-Hu-1 strain of SARS-CoV-2. mRNA-1273 consists of an mRNA Drug Substance that is manufactured into LNPs composed of the proprietary ionizable lipid, SM-102, and 3 commercially available lipids, cholesterol, 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), and PEG2000 DMG.
Study NCT04785144 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: mRNA-1273.351
Description: Lipid nanoparticle (LNP) dispersion containing an mRNA that encodes for the pre fusion stabilized spike protein of the B.1.351 variant SARS-CoV-2 strain. mRNA-1273.351 consists of an mRNA Drug Substance that is manufactured into LNPs composed of the proprietary ionizable lipid, SM-102, and 3 commercially available lipids, cholesterol, 1,2-distearoyl-sn-glycero-3-phosphocholine (DSPC), and PEG2000 DMG.
Study NCT05129657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product C
Description: P1012915, A nicotine pouch product with 8 mg of nicotine
Study NCT05955729 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pittsburgh Sleep Quality Index (PSQI)
Description: 24-question sleep quality assessment scale, a score > 5 indicates poor sleep quality
Study NCT05129657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product D
Description: P1012919, A nicotine pouch product with 12 mg of nicotine
Study NCT05129657 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Product N
Description: Nicorette® White Ice Mint 4 mg nicotine gum
Study NCT04628793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07258669
Description: PF-07258669 will be prepared as an oral solution and/or suspension given in escalating single doses to be determined
Study NCT06421506 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Less invasive surfactant administration during high flow nasal cannula treatment
Description: Surfactant distilled through a small tube inserted into the windpipe via the mouth whilst the baby is awake and supported with HFNC.
Study NCT04628793 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo will be prepared as an oral solution and/or suspension given in each cohort
Study NCT06029842 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Collaborative approach of clinical pharmacist with physicians in a medical center
Description: For those who allocated to the intervention group, the clinical pharmacist interviewed them at each monthly visit about 30 minutes before seeing physicians, the clinical pharmacist identified treatment related problems, provided medication counseling, answered questions asked by patients or physicians, encouraged compliance, offered instructions on self-monitoring of blood pressure and glucose levels, distributed educational materials about diabetes and emphasis was made on optimizing adherence to pharmacological and non- pharmacological therapy. the pharmacist interventions on treatment related problems (TRPs) and proposed patient care plans were discussed with treatng physicians who decided to accept or reject them.
Study NCT05714449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eye patch
Description: standard amblyopia treatment
Study NCT05794360 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACtive Children Enhance LEaRning and AttenTION (ACCELERATION)
Description: A diverse group of key informants (i.e., PE teachers, school athletic department director) and community stakeholders (i.e., professional soccer coaches, Houston Dynamo Academy director) were engaged to help the research team design, modify, and implement the ACCELERATION curriculum to ensure program relevance and appeal. There are several components that described below make our program design both comprehensive and highly adaptable for optimal reach and effectiveness. These include staff development training, parent workshops, on-site and virtual developmental programs, delivery and implementation support from community stakeholders, online resources, family engagement events, equipment donations to improve activity, and on-going support and mentoring services for parents and school-based educators.
Study NCT04932057 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Action observation Training
Description: Action observation training is a relatively new rehabilitation approach in which the subject is asked to carefully observe the actions presented through a video clip or performed by an operator.
Study NCT04932057 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Action Practice
Description: Participants perform an upper extremity functionality test a couple of times.
Study NCT04932057 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Observation
Description: Participants will watch a slide show of landscape
Study NCT05923606 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active tACS
Description: Active tACS will be administered over the left dorsolateral prefrontal cortex for approximately 25 minutes.
Study NCT05714449 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: After-image and MIT trainer
Description: Common clinical training for foveation
Study NCT06440122 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: FDG-PET Scan
Description: Positive for activated brown adipose tissue (SUVmax >1.5) FDG-PET scan
Study NCT06427096 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention
Description: The multifaceted interventions is comprised of the following components:~1. To establish a BP management team led by healthy family instructor. The team members also include family leaders and village doctors.~2. To conduct multifaceted intervention, which includes low-sodium diet, weight management, physical exercise, BP monitoring and antihypertensive treatment.
Study NCT05042323 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: TF-CBT-Short
Description: Participants receive either 4-5 sessions of TF-CBT-Skills or TF-CBT-Narr. If the participant still has significant PTSS they are provided with step two which is the components provided in the arm they did not receive.